257 related articles for article (PubMed ID: 22397031)
1. Clusterin in Alzheimer's disease.
Wu ZC; Yu JT; Li Y; Tan L
Adv Clin Chem; 2012; 56():155-73. PubMed ID: 22397031
[TBL] [Abstract][Full Text] [Related]
2. Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ.
Miners JS; Clarke P; Love S
Brain Pathol; 2017 May; 27(3):305-313. PubMed ID: 27248362
[TBL] [Abstract][Full Text] [Related]
3. Clusterin in Alzheimer's disease: a player in the biological behavior of amyloid-beta.
Li X; Ma Y; Wei X; Li Y; Wu H; Zhuang J; Zhao Z
Neurosci Bull; 2014 Feb; 30(1):162-8. PubMed ID: 24353014
[TBL] [Abstract][Full Text] [Related]
4. Clusterin: a forgotten player in Alzheimer's disease.
Nuutinen T; Suuronen T; Kauppinen A; Salminen A
Brain Res Rev; 2009 Oct; 61(2):89-104. PubMed ID: 19651157
[TBL] [Abstract][Full Text] [Related]
5. Intracellular and secreted forms of clusterin are elevated early in Alzheimer's disease and associate with both Aβ and tau pathology.
Shepherd CE; Affleck AJ; Bahar AY; Carew-Jones F; Halliday GM
Neurobiol Aging; 2020 May; 89():129-131. PubMed ID: 31813628
[TBL] [Abstract][Full Text] [Related]
6. The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.
Yu JT; Tan L
Mol Neurobiol; 2012 Apr; 45(2):314-26. PubMed ID: 22274961
[TBL] [Abstract][Full Text] [Related]
7. Clusterin mRNA and protein in Alzheimer's disease.
Baig S; Palmer LE; Owen MJ; Williams J; Kehoe PG; Love S
J Alzheimers Dis; 2012; 28(2):337-44. PubMed ID: 22232000
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology.
Holtzman DM
J Mol Neurosci; 2004; 23(3):247-54. PubMed ID: 15181253
[TBL] [Abstract][Full Text] [Related]
9. Isotopic N,N-dimethyl leucine tags for absolute quantification of clusterin and apolipoprotein E in Alzheimer's disease.
Liu Y; Zhang H; Zhong X; Li Z; Zetterberg H; Li L
J Proteomics; 2022 Apr; 257():104507. PubMed ID: 35124278
[TBL] [Abstract][Full Text] [Related]
10. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease.
DeMattos RB; O'dell MA; Parsadanian M; Taylor JW; Harmony JA; Bales KR; Paul SM; Aronow BJ; Holtzman DM
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10843-8. PubMed ID: 12145324
[TBL] [Abstract][Full Text] [Related]
11. Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release.
Donner L; Fälker K; Gremer L; Klinker S; Pagani G; Ljungberg LU; Lothmann K; Rizzi F; Schaller M; Gohlke H; Willbold D; Grenegard M; Elvers M
Sci Signal; 2016 May; 9(429):ra52. PubMed ID: 27221710
[TBL] [Abstract][Full Text] [Related]
12. Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease.
Zhou Y; Hayashi I; Wong J; Tugusheva K; Renger JJ; Zerbinatti C
PLoS One; 2014; 9(7):e103187. PubMed ID: 25051234
[TBL] [Abstract][Full Text] [Related]
13. The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide.
Narayan P; Orte A; Clarke RW; Bolognesi B; Hook S; Ganzinger KA; Meehan S; Wilson MR; Dobson CM; Klenerman D
Nat Struct Mol Biol; 2011 Dec; 19(1):79-83. PubMed ID: 22179788
[TBL] [Abstract][Full Text] [Related]
14. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer's disease neuropathology.
Chen F; Swartzlander DB; Ghosh A; Fryer JD; Wang B; Zheng H
Mol Neurodegener; 2021 Jan; 16(1):5. PubMed ID: 33517893
[TBL] [Abstract][Full Text] [Related]
15. Relevance of N-terminal residues for amyloid-β binding to platelet integrin α
Donner L; Gremer L; Ziehm T; Gertzen CGW; Gohlke H; Willbold D; Elvers M
Cell Signal; 2018 Oct; 50():121-130. PubMed ID: 29964150
[TBL] [Abstract][Full Text] [Related]
16. The Role of Clusterin Transporter in the Pathogenesis of Alzheimer's Disease at the Blood-Brain Barrier Interface: A Systematic Review.
Fareed MM; Qasmi M; Aziz S; Völker E; Förster CY; Shityakov S
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291661
[TBL] [Abstract][Full Text] [Related]
17. Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: Cholesterol metabolism and trafficking perspectives.
Dong HK; Gim JA; Yeo SH; Kim HS
Gene; 2017 Jan; 597():10-16. PubMed ID: 27773727
[TBL] [Abstract][Full Text] [Related]
18. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
[TBL] [Abstract][Full Text] [Related]
19. Genetic association between clusterin polymorphisms and Alzheimer's disease in a Japanese population.
Komatsu M; Shibata N; Kuerban B; Ohnuma T; Baba H; Arai H
Psychogeriatrics; 2011 Mar; 11(1):14-8. PubMed ID: 21447104
[TBL] [Abstract][Full Text] [Related]
20. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
